Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
How we work:
- PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
- COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
- BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you’ll make an impact:
As the Lead Statistician, you will spearhead the statistical efforts of one or more clinical programs, playing a key role in the clinical development plan, regulatory submissions, and overall data strategy. This role requires strategic involvement in program teams, authorship of statistical sections in study documents, and direct oversight of outsourced statistical functions.
- Act as the lead statistician of a clinical program, leading statistical efforts and representing biometrics functions on program teams. Make strategic contributions to the clinical development plan.
- Serve as the biostatistical lead for regulatory submissions and inspections, ensuring compliance with global regulatory standards.
- Contribute to the development of clinical protocols by authoring the statistical methods section and reviewing other sections for statistical accuracy.
- Develop and review statistical analysis plans for individual studies and integrated summaries of safety/efficacy (ISS/ISE). Create and edit statistical outputs shells.
- Provide statistical input during CRF design to ensure alignment with study objectives and analyze requirements. Oversee and quality control results from statistical programmers or CROs.
- Contribute to clinical study reports by authoring statistical sections and interpreting study results. Support the preparation of scientific publications and presentations.
- Manage relationships with CROs to ensure high-quality statistical outputs and compliance with study requirements.
- May manage direct reports, as needed, providing guidance and professional development.
Skills and experience you’ll bring:
- Advanced degree in Statistics or related field with minimum 6 years of clinical trial experience in a biotechnology or pharma company.
- Extensive knowledge of statistical methods for clinical trials and deep familiarity with FDA, EMA, and ICH guidelines.
- Expertise in SAS required; R or Python is advantageous. Experience with trial design software such as EAST or nQuery.
- Strong communication skills necessary for effective collaboration with cross-functional teams. Ability to communicate statistics to non-statisticians effectively; influence and ensure adoption of robust statistical methods.
- Exceptional ability to manage multiple priorities in a fast-paced environment.
- A strong passion for innovation in Biostatistics and continuous improvement in processes.
- Strong analytical and problem-solving abilities.
- Positive attitude and a collaborative spirit.
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.
Compensation
- Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
- The anticipated base salary range for this role is $195,000 – $275,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
- Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.
Skills Required
- Advanced degree in Statistics or related field
- Minimum 6 years of clinical trial experience in a biotechnology or pharma company
- Extensive knowledge of statistical methods for clinical trials
- Deep familiarity with FDA, EMA, and ICH guidelines
- Expertise in SAS
- Experience with R or Python
- Experience with trial design software such as EAST or nQuery
Kymera Therapeutics Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Kymera Therapeutics and has not been reviewed or approved by Kymera Therapeutics.
-
Fair & Transparent Compensation — Pay is considered market‑competitive for core scientific and leadership roles, with clearly posted ranges visible for U.S. openings. Feedback suggests strong base pay aligns with comments about high salary and good pay.
-
Equity Value & Accessibility — Employees are eligible to participate in broad‑based equity programs, including an equity incentive plan and an ESPP. Feedback suggests this ownership opportunity can meaningfully augment total compensation in a growth‑focused setting.
-
Leave & Time Off Breadth — Company‑wide office shutdowns, standard PTO, and summer schedules are promoted to help people unplug. Feedback suggests these practices contribute to a well‑rounded time‑off offering.
Kymera Therapeutics Insights
What We Do
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years








